Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Chem Sci ; 13(10): 2909-2918, 2022 Mar 09.
Artículo en Inglés | MEDLINE | ID: mdl-35382459

RESUMEN

Thiomaleimides undergo efficient intermolecular [2 + 2] photocycloaddition reactions and offer applications from photochemical peptide stapling to polymer crosslinking; however, the reactions are limited to the formation of the exo head-to-head isomers. Herein, we present an intramolecular variation which completely reverses the stereochemical outcome of this photoreaction, quantitatively generating endo adducts which minimise the structural disturbance of the disulfide staple and afford a 10-fold increase in quantum yield. We demonstrate the application of this reaction on a protein scaffold, using light to confer thiol stability to an antibody fragment conjugate. To understand more about this intriguing class of [2 + 2] photocycloadditions, we have used transient absorption spectroscopy (electronic and vibrational) to study the excited states involved. The initially formed S2 (π1π*) excited state is observed to decay to the S1 (n1π*) state before intersystem crossing to a triplet state. An accelerated intramolecular C-C bond formation provides evidence to explain the increased efficiency of the reaction, and the impact of the various excited states on the carbonyl vibrational modes is discussed.

2.
J Med Chem ; 61(5): 2111-2117, 2018 03 08.
Artículo en Inglés | MEDLINE | ID: mdl-29457898

RESUMEN

The aryloxy triester phosphoramidate prodrug approach has been used with success in drug discovery. Herein, we describe the first application of this prodrug technology to the monophosphate derivative of the phosphoantigen HMBPP and one of its analogues. Some of these prodrugs exhibited specific and potent activation of Vγ9/Vδ2 T-cells, which were then able to lyse bladder cancer cells in vitro. This work highlights the promise of this prodrug technology in the discovery of novel immunotherapeutics.


Asunto(s)
Amidas/síntesis química , Ácidos Fosfóricos/síntesis química , Profármacos/síntesis química , Subgrupos de Linfocitos T/inmunología , Amidas/farmacología , Células Cultivadas , Humanos , Inmunoterapia/métodos , Activación de Linfocitos/efectos de los fármacos , Organofosfatos/química , Ácidos Fosfóricos/farmacología , Profármacos/farmacología , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Especificidad del Receptor de Antígeno de Linfocitos T , Neoplasias de la Vejiga Urinaria/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA